A Phase1 Study of VIB9600

NCT03621605 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated due to tolerability issues.

Conditions

Safety Issues

Interventions

BIOLOGICAL: VIB9600
DRUG: Placebos

Sponsor

Amgen

Collaborators

[object Object]